洋地黄含有洋地黄毒甙、狄戈辛、西地兰等多种强心甙,是治疗急性和慢性心功能不全的基本药物,已有多年临床应用历史,疗效肯定,因此被许多国家药典所收载。洋地黄效价用生物检定法测定,这就需要有一种标准品。中国药典洋地黄生物检定用的是洋地黄国家标准品。中国药典洋地黄第四次国家标准品已在一九八○年六月选制好,标定工作也已于1981年底完成。 Digitalis contains digoxin, digoxin, cedilanid and other cardiac glycosides, is the treatment of acute and chronic heart failure basic drugs, has many years of clinical history, efficacy is affirmative, so many national pharmacopoeia Contained. Digitalis potency bioassay determination, which requires a standard. Chinese Pharmacopoeia digitalis biological test with digitalis National Standards. The fourth national standard of China Pharmacopoeia was prepared in June 1980 and the calibration was completed by the end of 1981.